PharVision Advisers »

Manhattan Associates shares owned by PharVision Advisers

Quarter-by-quarter ownership of Manhattan Associates (MANH) shares owned by PharVision Advisers from 13F filings

Historical chart of PharVision Advisers investment in Manhattan Associates

Tip: Access up to 7 years of quarterly data

All positions including Manhattan Associates held by PharVision Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Manhattan Associates by PharVision Advisers

Quarter filed Position value Share count Share price at filing
2025-09-30 $382k 1.9k 204.98

More positions owned by PharVision Advisers

Wayfair Cl A (W)
ExlService Holdings (EXLS)
Up Fintech Hldg Sponsored Ads (TIGR)
Array Technologies Com Shs (ARRY)
Sprouts Fmrs Mkt (SFM)
Corporacion Amer Arpts S A (CAAP)
Vertiv Holdings Com Cl A (VRT)
Zevra Therapeutics Com New (ZVRA)
Bowhead Specialty Hldgs Com Shs (BOW)
Lexinfintech Hldgs Adr (LX)
Euronet Worldwide (EEFT)
Rigel Pharmaceuticals (RIGL)
Masimo Corporation (MASI)
LSB Industries (LXU)
Bright Horizons Fam Sol In D (BFAM)

View all positions for PharVision Advisers

Top funds holding Manhattan Associates

Vanguard Group
BlackRock
Alliancebernstein
FMR
Morgan Stanley
AQR Capital Management
T. Rowe Price Investment Management
State Street Corporation
Geode Capital Management
Kayne Anderson Rudnick Investment Management
Swedbank AB
Franklin Resources
Neuberger Berman Group
Invesco
Citadel Advisors

View all funds holding Manhattan Associates